Camargo Pharmaceutical Services, a leading drug development organization specializing in the 505(b)(2) approval pathway, strengthens its leadership and expertise in pharmaceutics with the addition of Olu Aloba, Ph.D., to the team as senior director of pharmaceutics.
In his new role, Aloba will provide Camargo’s clients with pharmaceutical development and regulatory consulting with special emphasis on the 505(b)(2) pathway and will direct chemistry, manufacturing and control (CMC) aspects of drug and device development activities.
Help employers find you! Check out all the jobs and post your resume.